Discover the 5 stocks poised for growth before Nvidia acquires them. Viking's obesity drug study results stun experts, with Oppenheimer's Jay Olson praising them as 'almost flawless'. Delve into the 6 biggest pharmaceutical stock analyses. Listen to Recursion Pharmaceuticals CEO Chris Gibson's exclusive interview with Jim Cramer for insights.